IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients
Clinical trial NCT03227198 · UNKNOWN
Trial details
- NCT number
- NCT03227198
- Sponsor
- SCARM Institute, Tabriz, Iran
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2021-08-10
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.